Affiliation:
1. Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute & Department of Medical Parasitology
and Mycology, Urmia University of Medical Sciences, Urmia, Iran
2. Student Research Committee, Urmia
University of Medical Sciences, Urmia, Iran
3. Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran
Abstract
Background:
Leishmaniasis, caused by the Leishmania parasite, is one of the most important
tropical neglected diseases. The urgent search for effective, inexpensive, and preferably herbal
anti-leishmanial agents, is needed.
Objective:
Curcumin is a natural polyphenolic compound derived from turmeric that is well known for
its antioxidant, anti-inflammatory, anti-tumor, and anti-cancer activity.
Methods:
The present work evaluates the anti-leishmanial [Leishmania major] activity of curcumin.
The infected PBMCs were treated with curcumin. The ROS level at 6, 12, 24 h and gene expression
levels at 24, 48, and 72 h of PBMCs after treatment with curcumin were determined.
Results:
Based on the results, the curcumin concentrations of 268 μM [24 h] and 181.2 μM [72 h] were
defined as IC50 against L. major promastigotes. Treatment of L. major infected-peripheral blood mononuclear
cells [PBMCs] with IC50 concentrations of curcumin, depending on exposure time, significantly
induced the reactive oxygen species [ROS] generation and increased the expression levels of interferongamma
[IFN-γ], tumor necrosis factor-alpha [TNF-α], and nitric oxide synthase [iNOS] genes.
Conclusions:
These findings suggest the potential of curcumin against Leishmaniasis.
Funder
Research Project of the Cellular and Molecular Research Center of Urmia University of Medical Science
Publisher
Bentham Science Publishers Ltd.
Subject
Microbiology (medical),Pharmacology,Molecular Medicine,General Medicine